Renergen has developed the ground-breaking Cryo-VaccTM

Cryo-Vacc TM is a wholly owned subsidiary of Renergen Limited.

Renergen has developed the ground-breaking Cryo-VaccTM, (listed on the JSE and ASX) which enables the safe transportation of vaccines at extremely low temperatures, without the need for (an external power source) electrical power.